Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations

Clinical Cancer Research

Volumn 17, Issue 7, 2011, Pages 1731-1740

  Saeki, Hiroshi ^a   Kitao, Hiroyuki ^a   Yoshinaga, Keiji ^a   Nakanoko, Tomonori ^a   Kubo, Nobuhide ^a   Kakeji, Yoshihiro ^a   Morita, Masaru ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE MUTATION; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE MARKER; P53 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; ESOPHAGEAL NEOPLASMS; GENE FREQUENCY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LOSS OF HETEROZYGOSITY; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79953294169     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1996     Document Type: Article

References (42)

1. Weinberg RA. Tumor suppressor genes. Science 1991;254:1138-46. (Pubitemid 21917438)
2. Tuna M, Knuutila S, Mills GB. Uniparental disomy in cancer. Trends Mol Med 2009;15:120-8.
3. Henry I, Bonaiti-Pellié C, Chehensse V, Beldjord C, Schwartz C, Utermann G, et al. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 1991;351:665-7. (Pubitemid 21896666)
4. O'Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 2010;115:2731-9.
5. Maciejewski JP, Mufti GJ. Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood 2008;112:965-74.
6. Maciejewski JP, Tiu RV, O'Keefe C. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies. Br J Haematol 2009;146:479-88.
7. Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis. Clin Cancer Res 2007;13:4777-85. (Pubitemid 47294784)
8. Murthy SK, DiFrancesco LM, Ogilvie RT, Demetrick DJ. Loss of heterozygosity associated with uniparental disomy in breast carcinoma. Mod Pathol 2002;15:1241-50. (Pubitemid 35462990)
9. Andersen CL, Wiuf C, Kruhøffer M, Korsgaard M, Laurberg S, Ørntoft TF. Frequent occurrence of uniparental disomy in colorectal cancer. Carcinogenesis 2007;28:38-48.
10. Ogiwara H, Kohno T, Nakanishi H, Nagayama K, Sato M, Yokota J. Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer. Oncogene 2008;27: 4788-97.
11. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB Jr, Ajani JA, et al. Treatment outcomes of resected esophageal cancer. Ann Surg 2002;236:376-84.
12. Stein HJ, Siewert JR. Improved prognosis of resected esophageal cancer. World J Surg 2004;28:520-5. (Pubitemid 38802785)
13. Morita M, Yoshida R, Ikeda K, Egashira A, Oki E, Sadanaga N, et al. Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery 2008;143: 499-508.
14. Toh Y, Oki E, Ohgaki K, Sakamoto Y, Ito S, Egashira A, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol 2010; 15:135-44.
15. Morita M, Kumashiro R, Kubo N, Nakashima Y, Yoshida R, Yoshinaga K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol 2010;15:126-34.
16. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53. (Pubitemid 21917115)
17. Parenti AR, Rugge M, Frizzera E, Ruol A, Noventa F, Ancona E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 1995;19:1418-22. (Pubitemid 3007347)
18. Ito S, Ohga T, Saeki H, Nakamura T, Watanabe M, Tanaka S, et al. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis. Int J Cancer 2005;113:22-28. (Pubitemid 39507306)
19. Saeki H, Ohno S, Araki K, Egashira A, Kawaguchi H, Ikeda Y, et al. Alcohol consumption and cigarette smoking in relation to high frequency of p53 protein accumulation in oesophageal squamous cell carcinoma in the Japanese. Br J Cancer 2000;82:1892-94. (Pubitemid 30307407)
20. Saeki H, Ohno S, Miyazaki M, Araki K, Egashira A, Kawaguchi H, et al. p53 protein accumulation in multiple oesophageal squamous cell carcinoma: relationship to risk factors. Oncology 2002;62:175-9. (Pubitemid 34253088)
21. Saeki H, Kimura Y, Ito S, Miyazaki M, Ohga T. Biologic and clinical significance of squamous epithelial dysplasia of the esophagus. Surgery 2002;13:S22-7.
22. Miyazaki M, Ohno S, Futatsugi M, Saeki H, Ohga T, Watanabe M. The relation of alcohol consumption and cigarette smoking to the multiple occurrence of esophageal dysplasia and squamous cell carcinoma. Surgery 2002;131:S7-13.
23. Oki E, Zhao Y, Yoshida R, Egashira A, Ohgaki K, Morita M, et al. The difference in p53 mutations between cancers of the upper and lower gastrointestinal tract. Digestion 2009;79:33-9.
24. Egashira A, Morita M, Kakeji Y, Sadanaga N, Oki E, Honbo T, et al. p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries. Cancer Sci 2007;98:1152-6. (Pubitemid 46993534)
25. Oki E, Baba H, Tokunaga E, Nakamura T, Ueda N, Futatsugi M, et al. Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int J Cancer 2005;117:376-80. (Pubitemid 41429560)
26. Oki E, Tokunaga E, Nakamura T, Ueda N, Futatsugi M, Mashino K, et al. Genetic mutual relationship between PTEN and p53 in gastric cancer. Cancer Lett 2005;227:33-8.
27. Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, Hurst JA, et al. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 2006;38:1038-42. (Pubitemid 44325929)
28. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diag 2000;2:116-23.
29. Kallioniemi A, Kallioniemi OP, Waldman FM, Chen LC, Yu LC, Fung YK, et al. Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization. Cytogenet Cell Genet 1992;60:190-3.
30. Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, Garcia F, et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 2006;16:1136-48. (Pubitemid 44320401)
31. Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000;462:335-42. (Pubitemid 30190239)
32. Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001;22:1737-46. (Pubitemid 33064837)
33. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78. (Pubitemid 24289415)
34. Puisieux A, Lim S, Groopman J, Ozturk M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res 1991;51:6185-9.
35. Araki K, Wang B, Miyashita K, Cui Q, Ohno S, Baba H, et al. Frequent loss of heterozygosity but rare microsatellite instability in oesophageal cancer in Japanese and Chinese patients. Oncology 2004;67:151-8. (Pubitemid 39482684)
36. Tomasini R, Mak TW, Melino G. The impact of p53 and p73 on aneuploidy and cancer. Trends Mol Med 2008;18:244-52.
37. Thompson SL, Compton DA. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 2010;188:369-81.
38. Fitzgibbon J, Smith LL, Raghavan M, Smith ML, Debernardi S, Skoulakis S, et al. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res 2005;65:9152-4. (Pubitemid 41507976)
39. Griffiths M, Mason J, Rindl M, Akiki S, McMullan D, Stinton V, et al. Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations. Leukemia 2005;19:2355-8. (Pubitemid 41741640)
40. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, et al. Wide-spread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005;106:2162-8. (Pubitemid 41291734)
41. Qin YR, Wang LD, Fan ZM, Kwong D, Guan XY. Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China. World J Gastroenterol 2008;28:1828-35. (Pubitemid 351523811)
42. Sakai N, Kajiyama Y, Iwanuma Y, Tomita N, Amano T, Isayama F, et al. Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions. Dis Esophagus 2010;23:415-21.